Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |